In general, pedometers are most accurate for assessing steps, less accurate for assessing distance, and even less accurate for assessing kilocalories.

The KZ, YX200, NL, and YX701 appear to be suitable for most research purposes. Given the potential for pedometers in physical activity research, it is necessary that there be consistency across studies in the measurement of "steps per day."

Due to the variation that exists among models in regard to the internal mechanism and sensitivity, not all pedometers count steps accurately. Thus, it is important for researchers who use pedometers to assess physical activity to be aware of their accuracy and reliability.

The purpose of this study was to develop a new two-regression model relating Actigraph activity counts to energy expenditure over a wide range of physical activities. Forty-eight participants [age 35 yr (11.4)] performed various activities chosen to represent sedentary, light, moderate, and vigorous intensities. Eighteen activities were split into three routines with each routine being performed by 20 individuals, for a total of 60 tests. Forty-five tests were randomly selected for the development of the new equation, and 15 tests were used to cross-validate the new equation and compare it against already existing equations. During each routine, the participant wore an Actigraph accelerometer on the hip, and oxygen consumption was simultaneously measured by a portable metabolic system. For each activity, the coefficient of variation (CV) for the counts per 10 s was calculated to determine whether the activity was walking/running or some other activity. If the CV was 10, a lifestyle/leisure time physical activity regression was used. In the cross-validation group, the mean estimates using the new algorithm (2-regression model with an inactivity threshold) were within 0.75 metabolic equivalents (METs) of measured METs for each of the activities performed (P >or= 0.05), which was a substantial improvement over the single-regression models. The new algorithm is more accurate for the prediction of energy expenditure than currently published regression equations using the Actigraph accelerometer.

The aim of this investigation was to develop and test two artificial neural networks (ANN) to apply to physical activity data collected with a commonly used uniaxial accelerometer. The first ANN model estimated physical activity metabolic equivalents (METs), and the second ANN identified activity type. Subjects (n = 24 men and 24 women, mean age = 35 yr) completed a menu of activities that included sedentary, light, moderate, and vigorous intensities, and each activity was performed for 10 min. There were three different activity menus, and 20 participants completed each menu. Oxygen consumption (in ml x kg(-1) x min(-1)) was measured continuously, and the average of minutes 4-9 was used to represent the oxygen cost of each activity. To calculate METs, activity oxygen consumption was divided by 3.5 ml x kg(-1) x min(-1) (1 MET). Accelerometer data were collected second by second using the Actigraph model 7164. For the analysis, we used the distribution of counts (10th, 25th, 50th, 75th, and 90th percentiles of a minute's second-by-second counts) and temporal dynamics of counts (lag, one autocorrelation) as the accelerometer feature inputs to the ANN. To examine model performance, we used the leave-one-out cross-validation technique. The ANN prediction of METs root-mean-squared error was 1.22 METs (confidence interval: 1.14-1.30). For the prediction of activity type, the ANN correctly classified activity type 88.8% of the time (confidence interval: 86.4-91.2%). Activity types were low-level activities, locomotion, vigorous sports, and household activities/other activities. This novel approach of applying ANNs for processing Actigraph accelerometer data is promising and shows that we can successfully estimate activity METs and identify activity type using ANN analytic procedures.

In overweight and obese individuals, a piezo-electric pedometer (NL) is more accurate than a spring-levered pedometer (SW), especially at slower walking speeds. In addition, it appears that pedometer tilt; more so than waist circumference and BMI, was the most important factor influencing the accuracy of the SW. The NL accuracy was not affected by pedometer tilt, waist circumference, or BMI.

Purpose:This study was designed to examine the relationship between active transportation (defined as the percentage of trips taken by walking, bicycling, and public transit) and obesity rates (BMI ≥ 30 kg · m−2) in different countries.Methods:National surveys of travel behavior and health indicators in Europe, North America, and Australia were used in this study; the surveys were conducted in 1994 to 2006. In some cases raw data were obtained from national or federal agencies and then analyzed, and in other cases summary data were obtained from published reports.Results:Countries with the highest levels of active transportation generally had the lowest obesity rates. Europeans walked more than United States residents (382 versus 140 km per person per year) and bicycled more (188 versus 40 km per person per year) in 2000.Discussion:Walking and bicycling are far more common in European countries than in the United States, Australia, and Canada. Active transportation is inversely related to obesity in these countries. Although the results do not prove causality, they suggest that active transportation could be one of the factors that explain international differences in obesity rates.

Step counting has long been used as a method of measuring distance. Starting in the mid-1900s, researchers became interested in using steps per day to quantify ambulatory physical activity. This line of research gained momentum after 1995, with the introduction of reasonably accurate spring-levered pedometers with digital displays. Since 2010, the use of accelerometer-based “activity trackers” by private citizens has skyrocketed. Steps have several advantages as a metric for assessing physical activity: they are intuitive, easy to measure, objective, and they represent a fundamental unit of human ambulatory activity. However, since they measure a human behavior, they have inherent biological variability; this means that measurements must be made over 3–7 days to attain valid and reliable estimates. There are many different kinds of step counters, designed to be worn on various sites on the body; all of these devices have strengths and limitations. In cross-sectional studies, strong associations between steps per day and health variables have been documented. Currently, at least eight prospective, longitudinal studies using accelerometers are being conducted that may help to establish dose–response relationships between steps/day and health outcomes. Longitudinal interventions using step counters have shown that they can help inactive individuals to increase by 2500 steps per day. Step counting is useful for surveillance, and studies have been conducted in a number of countries around the world. Future challenges include the need to establish testing protocols and accuracy standards, and to decide upon the best placement sites. These challenges should be addressed in order to achieve harmonization between studies, and to accurately quantify dose–response relationships.